Citations 1
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis
Abro, Brooj , Maurer, Matthew J. , Burack, Richard , Chapman, Jennifer R. , Cohen, Jonathon B. , Friedberg, Jonathan W. , Inghirami, Giorgio , Lossos, Izidore S. , Martin, Peter W., McDonnell, Timothy J. , Riska, Shaun M., Flowers, Christopher R. , Burack, W Richard , Cohen, Jonathon B , Inghirami, Giorgio , Link, Brian K , Lossos, Izidore S , Nastoupil, Loretta J , Vega, Francisco , Cerhan, James R , Feldman, Andrew L , Maurer, Matthew , Habermann, Thomas M. , Kahl, Brad S. , Larson, Melissa C. , Link, Brian K. , Martin, Peter, Nastoupil, Loretta J. , Syrbu, Sergei , Vega, Francisco , Vij, Kiran R , Cerhan, James R. , Jaye, David L. , Feldman, Andrew L.
Blood | September 10, 2024 | Volume: 144 | Issue: 19 | Pages: 2063-2066
Abstract Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.